
### [NCIT:C25765](http://purl.obolibrary.org/obo/NCIT_C25765)
**Label:** Secondary Acute Myeloid Leukemia

**Subclasses:** [NCIT:C4037](http://purl.obolibrary.org/obo/NCIT_C4037) (Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome), [NCIT:C27755](http://purl.obolibrary.org/obo/NCIT_C27755) (Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia), [NCIT:C27754](http://purl.obolibrary.org/obo/NCIT_C27754) (Alkylating Agent-Related Acute Myeloid Leukemia), [NCIT:C8252](http://purl.obolibrary.org/obo/NCIT_C8252) (Therapy-Related Acute Myeloid Leukemia), 

**Class expressions from DL-Learner:**

- [NCIT:C35788](http://purl.obolibrary.org/obo/NCIT_C35788) (Hypercellular Bone Marrow) 66.67%
- Thing 51.13%
- [NCIT:C36278](http://purl.obolibrary.org/obo/NCIT_C36278) (Finding by Site or System) 39.03%
- [NCIT:C77140](http://purl.obolibrary.org/obo/NCIT_C77140) (Clinical Test Result) 38.71%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 35.85%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 35.25%
- [NCIT:C37067](http://purl.obolibrary.org/obo/NCIT_C37067) (Neoplastic Myeloid Blast) 32.48%
- [NCIT:C37064](http://purl.obolibrary.org/obo/NCIT_C37064) (Neoplastic Blast) 29.17%
- [NCIT:C41063](http://purl.obolibrary.org/obo/NCIT_C41063) (Neoplastic Myeloid Cell) 28.14%
- [NCIT:C37042](http://purl.obolibrary.org/obo/NCIT_C37042) (Abnormal Myeloid Cell) 25.51%
- [NCIT:C25553](http://purl.obolibrary.org/obo/NCIT_C25553) (Leukemic Cell) 24.57%
- [NCIT:C37060](http://purl.obolibrary.org/obo/NCIT_C37060) (Neoplastic Hematopoietic and Lymphoid Cell) 21.48%
- [NCIT:C36987](http://purl.obolibrary.org/obo/NCIT_C36987) (Abnormal Hematopoietic and Lymphoid Cell) 20.92%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 19.90%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 19.15%


